Phytochemical and Pharmacological Profiles of Three Fagopyrum Buckwheats.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing in vitro, animal, and chemical isolation studies without human clinical trials.
PubMed 27104519 · doi:10.3390/ijms17040589
What was done
The authors compiled literature from major databases (MEDLINE, PubMed, Scholar, Elsevier, Springer, Wiley, and CNKI) to review the phytochemical composition and pharmacological properties of three buckwheat species: Fagopyrum esculentum, Fagopyrum tataricum, and Fagopyrum dibotrys.
What was found
The review cataloged 106 isolated compounds classified into flavonoids, phenolics, fagopyritols, triterpenoids, steroids, and fatty acids, with flavonoids and phenolics identified as the primary active classes. Preclinical in vitro and in vivo studies indicated antitumor, antioxidant, anti-inflammatory, hepatoprotective, and anti-diabetic activities. The abstract reports no quantitative effect sizes or numerical outcome data.
Why it matters
This paper consolidates known chemical profiles and preclinical bioactivities across three buckwheat species to support future research into bioactive constituents and mechanism of action.
Limits
The review relies on preclinical bench and animal experiments without human clinical trial data. The abstract lacks formal systematic review methodology, quality appraisal, a specific count of included studies, and quantitative safety or efficacy metrics.
Cited by
- supports Tartary buckwheat contains over 150 different immune-active phytochemicals.